Detalhe da pesquisa
1.
Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?
Can J Psychiatry
; 66(7): 645-656, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243011
2.
Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study.
Can J Psychiatry
; 62(12): 827-836, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28673098
3.
Monitoring of metabolic adverse events of second-generation antipsychotics in a naive paediatric population followed in mental health outpatient and inpatient clinical settings: MEMAS prospective study protocol.
BMJ Open
; 11(1): e040764, 2021 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33455928
4.
Impact of Psychoactive Drug Use on Developing Obesity among Children and Adolescents with Autism Spectrum Diagnosis: A Nested Case-Control Study.
Child Obes
; 15(2): 131-141, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30668140